Understanding how inflammation affects COVID-19 outcomes
Role and Mitigation of Inflammasomes and Inflammation During COVID-19
This study is looking at how inflammation affects people with COVID-19, especially those who develop serious breathing problems, to find better ways to treat them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10874750 on NIH RePORTER |
What this research studies
This research investigates the role of inflammasomes and inflammatory responses in patients suffering from COVID-19, particularly focusing on acute respiratory distress syndrome (ARDS). By examining how specific cytokines, such as IL-1 and TNF, contribute to the severity of ARDS, the study aims to uncover mechanisms that could lead to improved treatment strategies. The research employs a combination of laboratory experiments and clinical data analysis to explore the pathways involved in inflammation during COVID-19. Patients may benefit from insights gained that could inform new therapeutic approaches to manage severe cases of the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with COVID-19 who are experiencing severe symptoms or complications such as ARDS.
Not a fit: Patients with mild COVID-19 symptoms or those who have fully recovered from the virus may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with severe COVID-19 and ARDS.
How similar studies have performed: Previous clinical trials have shown promising results with IL-1 inhibitors in COVID-19 patients, indicating that this area of research has potential for success.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Ting, Jenny P — Univ of North Carolina Chapel Hill
- Study coordinator: Ting, Jenny P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.